Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1990; Volume 37,Issue 2
  • You have access
    Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
    H J Guyda, L Mathieu, W Lai, D Manchester, S L Wang, S Ogilvie and K T Shiverick
    Molecular Pharmacology February 1990, 37 (2) 137-143;
  • You have access
    Sodium channel comodification with full activator reveals veratridine reaction dynamics.
    G Wang, M Dugas, B I Armah and P Honerjäger
    Molecular Pharmacology February 1990, 37 (2) 144-148;
  • You have access
    Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.
    V Ramkumar, W W Barrington, K A Jacobson and G L Stiles
    Molecular Pharmacology February 1990, 37 (2) 149-156;
  • You have access
    Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
    Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
    Molecular Pharmacology February 1990, 37 (2) 157-163;
  • You have access
    A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes.
    A Berkovich, P McPhie, M Campagnone, A Guidotti and P Hensley
    Molecular Pharmacology February 1990, 37 (2) 164-172;
  • You have access
    Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    B J Murphy, C A Rogers, R K Sunahara, S Lemaire and B S Tuana
    Molecular Pharmacology February 1990, 37 (2) 173-181;
  • You have access
    In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.
    J M Voigt, T T Kawabata, J P Burke, M V Martin, F P Guengerich and J Baron
    Molecular Pharmacology February 1990, 37 (2) 182-191;
  • You have access
    Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
    S P Cole, H F Downes, S E Mirski and D J Clements
    Molecular Pharmacology February 1990, 37 (2) 192-197;
  • You have access
    Glucocorticoid regulation of polycyclic aromatic hydrocarbon induction of cytochrome P450IA1, glutathione S-transferases, and NAD(P)H:quinone oxidoreductase in cultured fetal rat hepatocytes.
    A J Sherratt, D E Banet and R A Prough
    Molecular Pharmacology February 1990, 37 (2) 198-205;
  • You have access
    Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    T J Torphy and L B Cieslinski
    Molecular Pharmacology February 1990, 37 (2) 206-214;
  • You have access
    Regulation of prolactin gene transcription in vivo: interactions between estrogen, pimozide, and alpha-ergocryptine.
    J D Shull and J Gorski
    Molecular Pharmacology February 1990, 37 (2) 215-221;
  • You have access
    Maitotoxin: effects on calcium channels, phosphoinositide breakdown, and arachidonate release in pheochromocytoma PC12 cells.
    O H Choi, W L Padgett, Y Nishizawa, F Gusovsky, T Yasumoto and J W Daly
    Molecular Pharmacology February 1990, 37 (2) 222-230;
  • You have access
    Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    E Meller, M Goldstein and K Bohmaker
    Molecular Pharmacology February 1990, 37 (2) 231-237;
  • You have access
    Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
    U Kragh-Hansen, S O Brennan, M Galliano and O Sugita
    Molecular Pharmacology February 1990, 37 (2) 238-242;
  • You have access
    Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
    L Y Liu-Chen, S X Li and R J Tallarida
    Molecular Pharmacology February 1990, 37 (2) 243-250;
  • You have access
    Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes alpha, mu, and pi.
    K Berhane and B Mannervik
    Molecular Pharmacology February 1990, 37 (2) 251-254;
  • You have access
    Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
    D J Thomas, A Sadler, V V Subrahmanyam, D Siegel, M J Reasor, D Wierda and D Ross
    Molecular Pharmacology February 1990, 37 (2) 255-262;
  • You have access
    Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites.
    A L Morrow, J R Pace, R H Purdy and S M Paul
    Molecular Pharmacology February 1990, 37 (2) 263-270;
  • You have access
    Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
    D C Mills, K Hunchak, D W Karl and E P Kirby
    Molecular Pharmacology February 1990, 37 (2) 271-277;
  • You have access
    N-Methyl-D-aspartate and quisqualate/DL-alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptors: differential regulation by phospholipase C treatment.
    G Massicotte, M Kessler, G Lynch and M Baudry
    Molecular Pharmacology February 1990, 37 (2) 278-285;
  • You have access
    Requirements for the activation of protein kinase C: comparison of the molecular geometries of phorbol and diacylglycerol.
    U Leli, G Hauser and M Froimowitz
    Molecular Pharmacology February 1990, 37 (2) 286-295;
  • You have access
    Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
    R A Johnson and M L Toews
    Molecular Pharmacology February 1990, 37 (2) 296-303;
  • You have access
    Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.
    R R Huang, R N Dehaven, A H Cheung, R E Diehl, R A Dixon and C D Strader
    Molecular Pharmacology February 1990, 37 (2) 304-310;
  • You have access
    Aniline-, phenylhydroxylamine-, nitrosobenzene-, and nitrobenzene-induced hemoglobin thiyl free radical formation in vivo and in vitro.
    K R Maples, P Eyer and R P Mason
    Molecular Pharmacology February 1990, 37 (2) 311-318;
  • You have access
    Enantioselective S-oxygenation of para-methoxyphenyl-1,3-dithiolane by various tissue preparations: effect of estradiol.
    J R Cashman, L D Olsen, C E Lambert and M J Presas
    Molecular Pharmacology February 1990, 37 (2) 319-327;
  • You have access
    Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell lines.
    R L Blakley, F C Harwood and K D Huff
    Molecular Pharmacology February 1990, 37 (2) 328-332;
  • You have access
    Enantioselective S-oxygenation of 2-aryl-1,3-dithiolanes by rabbit lung enzyme preparations.
    J R Cashman and D E Williams
    Molecular Pharmacology February 1990, 37 (2) 333-339;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 37, Issue 2
1 Feb 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Nelfinavir and PXR
  • P2X7 Positive Modulator Structure-Activity Relationship
  • Coronavirus in the Brain and the Impact of Smoking
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics